VEGF antagonist formulations suitable for intravitreal administration | Patent Publication Number 20200017572

US 20200017572 A1
Patent NumberUS 11066458 B2
Application Number16582486
Filled DateSep 25, 2019
Priority DateJun 16, 2006
Publication DateJan 16, 2020
Original AssigneeRegeneron Pharmaceuticals
Current AssigneeRegeneron Pharmaceuticals
Inventor/ApplicantsDaniel DIX
Kelly Frye
Kelly FRYE
Daniel Dix
Eric Furfine
Kenneth Graham
Kenneth GRAHAM
Eric FURFINE
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.